262 related articles for article (PubMed ID: 20037585)
1. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.
Ise W; Kohyama M; Nutsch KM; Lee HM; Suri A; Unanue ER; Murphy TL; Murphy KM
Nat Immunol; 2010 Feb; 11(2):129-35. PubMed ID: 20037585
[TBL] [Abstract][Full Text] [Related]
2. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
Friedline RH; Brown DS; Nguyen H; Kornfeld H; Lee J; Zhang Y; Appleby M; Der SD; Kang J; Chambers CA
J Exp Med; 2009 Feb; 206(2):421-34. PubMed ID: 19188497
[TBL] [Abstract][Full Text] [Related]
3. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
4. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
5. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
6. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.
Pacholczyk R; Kern J; Singh N; Iwashima M; Kraj P; Ignatowicz L
Immunity; 2007 Sep; 27(3):493-504. PubMed ID: 17869133
[TBL] [Abstract][Full Text] [Related]
7. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Yi LA; Hajialiasgar S; Chuang E
Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
[TBL] [Abstract][Full Text] [Related]
9. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Kwon H; Jun HS; Khil LY; Yoon JW
J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
[TBL] [Abstract][Full Text] [Related]
10. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
11. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
12. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
13. Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis.
Sharma R; Ju AC; Kung JT; Fu SM; Ju ST
J Immunol; 2008 Nov; 181(10):6934-41. PubMed ID: 18981113
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.
Gattinoni L; Ranganathan A; Surman DR; Palmer DC; Antony PA; Theoret MR; Heimann DM; Rosenberg SA; Restifo NP
Blood; 2006 Dec; 108(12):3818-23. PubMed ID: 16882704
[TBL] [Abstract][Full Text] [Related]
15. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
17. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Zhang X; Izikson L; Liu L; Weiner HL
J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
[TBL] [Abstract][Full Text] [Related]
18. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.
Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604
[TBL] [Abstract][Full Text] [Related]
19. TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells.
Catalfamo M; Tai X; Karpova T; McNally J; Henkart PA
Immunology; 2008 Sep; 125(1):70-9. PubMed ID: 18397268
[TBL] [Abstract][Full Text] [Related]
20. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
Vasu C; Prabhakar BS; Holterman MJ
J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
